Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice

Journal of Clinical Investigation

Volumn 118, Issue 8, 2008, Pages 2771-2784

  Kang, Min Jong ^a   Chun, Geun Lee ^a   Lee, Jae Young ^a   Dela Cruz, Charles S ^a   Chen, Zhijian J ^b   Enelow, Richard ^a   Elias, Jack A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; GAMMA INTERFERON; INITIATION FACTOR 2ALPHA; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 23; PROTEIN KINASE R; TOLL LIKE RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EMPHYSEMA; INFLUENZA; INNATE IMMUNITY; LUNG FIBROSIS; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

ANIMALS; EIF-2 KINASE; EUKARYOTIC INITIATION FACTOR-2; IMMUNITY, NATURAL; INTERFERON TYPE I; INTERLEUKIN-12; INTERLEUKIN-18; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLY I-C; POLYMERS; PULMONARY EMPHYSEMA; SULFONIC ACIDS; TOBACCO SMOKE POLLUTION; VIRUS DISEASES; VIRUSES;

EID: 48749097634     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32709     Document Type: Article

References (55)

1. Hogg, J.C., et al. 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350:2645-2653.
2. Senior, R.M., and Shapiro, S.D. 1998. Chronic obstructive pulmonary disease: epidemiology, pathophysiology, and pathogenesis. In Fishman's pulmonary diseases and disorders. A.P. Fishman, et al., editors. McGraw-Hill. New York, New York, USA. 659-681.
3. Sutherland, E.R., and Cherniack, R.M. 2004. Management of chronic obstructive pulmonary disease. N. Engl. J. Med. 350:2689-2697.
4. Hurst, J.R., Donaldson, G.C., Wilkinson, T.M., Perera, W.R., and Wedzicha, J.A. 2004. Relationships between the common cold and exacerbation frequency in COPD. Eur. Respir. J. 24(Suppl. 48):686s.
5. Saetta, M., et al. 1999. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160:711-717.
6. Saetta, M., et al. 1994. Airway eosinophilia in chronic bronchitis during exacerbations. Am. J. Respir. Crit. Care Med. 150:1646-1652.
7. Segura-Valdez, L., et al. 2000. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest. 117:684-694.
8. Yokohori, N., Aoshiba, K., and Nagai, A. 2004. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest. 125:626-632.
9. Donaldson, G.C., et al. 2005. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest. 128:1995-2004.
10. Sapey, E., and Stockley, R.A. 2006. COPD exacerbations. 2: aetiology. Thorax. 61:250-258.
11. Donaldson, G.C., Seemungal, T.A., Bhowmik, A., and Wedzicha, J.A. 2000. The relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 57:847-852.
12. Mallia, P., et al. 2007. Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. Curr. Pharm. Des. 13:73-97.
13. Mallia, P., and Johnston, S.L. 2006. How viral infections cause exacerbation of airway diseases. Chest. 130:1203-1210.
14. Kanner, R.E., Anthonisen, N.R., and Connett, J.E. 2001. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am. J. Respir. Crit. Care Med. 164:358-364.
15. Wedzicha, J.A. 2004. Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 1:115-120.
16. Ko, F.W., et al. 2007. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. Chest. 131:44-52.
17. O'Gorman, C., McHenry, E., and Coyle, P.V. 2006. Human metapneumovirus in adults: a short case series. Eur. J. Clin. Microbiol. Infect. Dis. 25:190-192.
18. Sajjan, U.S., et al. 2006. H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression. FASEB J. 20:2121-2123.
19. Bhowmik, A., Seemungal, T.A., Sapsford, R.J., and Wedzicha, J.A. 2000. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 55:114-120.
20. Seemungal, T., et al. 2001. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 164:1618-1623.
21. Tan, W.C., et al. 2003. Epidemiology of respiratory viruses in patients hospitalized with nearfatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am. J. Med. 115:272-277.
22. Arcavi, L., and Benowitz, N.L. 2004. Cigarette smoking and infection. Arch. Intern. Med. 164:2206-2216.
23. Cohen, S., Tyrrell, D.A., Russell, M.A., Jarvis, M.J., and Smith, A.P. 1993. Smoking, alcohol consumption, and susceptibility to the common cold. Am. J. Public Health. 83:1277-1283.
24. Kark, J.D., and Lebiush, M. 1981. Smoking and epidemic influenza-like illness in female military recruits: a brief survey. Am. J. Public Health. 71:530-532.
25. Kark, J.D., Lebiush, M., and Rannon, L. 1982. Cigarette smoking as a risk factor for epidemic a(h1n1) influenza in young men. N. Engl. J. Med. 307:1042-1046.
26. Papi, A., et al. 2006. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am. J. Respir. Crit. Care Med. 173:1114-1121.
27. Barr, J., et al. 2007. Nicotine induces oxidative stress and activates nuclear transcription factor kappa B in rat mesencephalic cells. Mol. Cell. Biochem. 297:93-99.
28. Sopori, M. 2002. Effects of cigarette smoke on the immune system. Nat. Rev. Immunol. 2:372-377.
29. D'Hulst, A.I., et al. 2005. Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required? Respir. Res. 6:147.
30. Gebel, S., et al. 2006. The kinetics of transcriptomic changes induced by cigarette smoke in rat lungs reveals a specific program of defense, inflammation, and circadian clock gene expression. Toxicol. Sci. 93:422-431.
31. Hodge, S., Hodge, G., Scicchitano, R., Reynolds, P.N., and Holmes, M. 2003. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol. Cell Biol. 81:289-296.
32. Vlahos, R., Bozinovski, S., Hamilton, J.A., and Anderson, G.P. 2006. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophagecolony stimulating factor (GM-CSF). Pharmacol. Ther. 112:106-115.
33. Schleimer, R.P. 2005. Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"? Proc. Am. Thorac. Soc. 2:342-346 discussion 371-342.;
34. Kang, M.J., et al. 2007. IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. J. Immunol. 178:1948-1959.
35. Kumar, H., et al. 2006. Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 203:1795-1803.
36. Sun, Q., et al. 2006. The specific and essential role of MAVS in antiviral innate immune responses. Immunity. 24:633-642.
37. Kasahara, Y., et al. 2000. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. 106:1311-1319.
38. Aoshiba, K., Yokohori, N., and Nagai, A. 2003. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am. J. Respir. Cell Mol. Biol. 28:555-562.
39. Petrache, I., et al. 2005. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat. Med. 11:491-498.
40. Der, S.D., Yang, Y.L., Weissmann, C., and Williams, B.R. 1997. A double-stranded RNA-activated protein kinase-dependent pathway mediating stressinduced apoptosis. Proc. Natl. Acad. Sci. U. S. A. 94:3279-3283.
41. Garcia, M.A., et al. 2006. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 70:1032-1060.
42. Guerra, S., Lopez-Fernandez, L.A., Garcia, M.A., Zaballos, A., and Esteban, M. 2006. Human gene profiling in response to the active protein kinase, interferon-induced serine/threonine protein kinase (PKR), in infected cells. Involvement of the transcription factor ATF-3 IN PKR-induced apoptosis. J. Biol. Chem. 281:18734-18745.
43. Hsu, L.C., et al. 2004. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature. 428:341-345.
44. Robbins, C.S., et al. 2006. Cigarette smoke impacts immune inflammatory responses to influenza in mice. Am. J. Respir. Crit. Care Med. 174:1342-1351.
45. Wilkinson, T.M., Donaldson, G.C., Johnston, S.L., Openshaw, P.J., and Wedzicha, J.A. 2006. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 173:871-876.
46. Dalton, D.K., et al. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 259:1739- 1742.
47. Hoshino, K., et al. 1999. Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J. Immunol. 162:5041-5044.
48. Yang, Y.L., et al. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14:6095-6106.
49. Alexopoulou, L., Holt, A.C., Medzhitov, R., and Flavell, R.A. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:732-738.
50. Hautamaki, R.D., Kobayashi, D.K., Senior, R.M., and Shapiro, S.D. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 277:2002-2004.
51. Liu, J., et al. 2005. Requirement for tumor necrosis factor-receptor 2 in alveolar chemokine expression depends upon the form of the ligand. Am. J. Respir. Cell Mol. Biol. 33:463-469.
52. Reed, L.J., and Muench, H. 1938. A simple method of estimating 50% endpoints. Am. J. Hyg. 27:493-497.
53. Zheng, T., et al. 2005. Role of cathepsin S-dependent epithelial cell apoptosis in IFN-gamma-induced alveolar remodeling and pulmonary emphysema. J. Immunol. 174:8106-8115.
54. Zheng, T., et al. 2000. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinaseand cathepsin-dependent emphysema. J. Clin. Invest. 106:1081-1093.
55. Halbower, A.C., Mason, R.J., Abman, S.H., and Tuder, R.M. 1994. Agarose infiltration improves morphology of cryostat sections of lung. Lab. Invest. 71:149-153.